128 related articles for article (PubMed ID: 17357832)
1. Synthetic serine protease inhibitor, gabexate mesilate, prevents nuclear factor-kappaB activation and increases TNF-alpha-mediated apoptosis in human pancreatic cancer cells.
Takahashi H; Funahashi H; Sawai H; Matsuo Y; Yamamoto M; Okada Y; Takeyama H; Manabe T
Dig Dis Sci; 2007 Oct; 52(10):2646-52. PubMed ID: 17357832
[TBL] [Abstract][Full Text] [Related]
2. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
Uchiba M; Okajima K; Kaun C; Binder BR; Wojta J
Crit Care Med; 2003 Apr; 31(4):1147-53. PubMed ID: 12682486
[TBL] [Abstract][Full Text] [Related]
3. Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes.
Yuksel M; Okajima K; Uchiba M; Okabe H
J Pharmacol Exp Ther; 2003 Apr; 305(1):298-305. PubMed ID: 12649382
[TBL] [Abstract][Full Text] [Related]
4. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.
McDade TP; Perugini RA; Vittimberga FJ; Carrigan RC; Callery MP
J Surg Res; 1999 May; 83(1):56-61. PubMed ID: 10210643
[TBL] [Abstract][Full Text] [Related]
5. Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
Brandi G; Tavolari S; Guarnieri T; Di Marco M; Paterini P; Macchini M; Di Girolamo S; Papi A; De Rosa F; Biasco G
Pancreas; 2014 Jan; 43(1):53-63. PubMed ID: 24201777
[TBL] [Abstract][Full Text] [Related]
6. Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
Furukawa K; Ohashi T; Haruki K; Fujiwara Y; Iida T; Shiba H; Uwagawa T; Kobayashi H; Yanaga K
Cancer Lett; 2011 Jul; 306(1):92-8. PubMed ID: 21482023
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
8. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
[TBL] [Abstract][Full Text] [Related]
9. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
[TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer.
Shirai Y; Shiba H; Iwase R; Haruki K; Fujiwara Y; Furukawa K; Uwagawa T; Ohashi T; Yanaga K
Cancer Lett; 2016 Jan; 370(2):177-84. PubMed ID: 26546875
[TBL] [Abstract][Full Text] [Related]
11. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Fujiwara Y; Furukawa K; Haruki K; Shimada Y; Iida T; Shiba H; Uwagawa T; Ohashi T; Yanaga K
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):731-9. PubMed ID: 21484229
[TBL] [Abstract][Full Text] [Related]
12. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hidaka S; Iwasaka H; Hagiwara S; Noguchi T
J Surg Res; 2011 Jan; 165(1):142-50. PubMed ID: 19766246
[TBL] [Abstract][Full Text] [Related]
13. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis.
Nagasaki K; Schem C; von Kaisenberg C; Biallek M; Rösel F; Jonat W; Maass N
Int J Cancer; 2003 Jul; 105(4):454-8. PubMed ID: 12712434
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
[TBL] [Abstract][Full Text] [Related]
15. Differential cytokine response in host defence mechanisms triggered by gram-negative and gram-positive bacteria, and the roles of gabexate mesilate, a synthetic protease inhibitor.
Iwadou H; Morimoto Y; Iwagaki H; Sinoura S; Chouda Y; Kodama M; Yoshioka T; Saito S; Yagi T; Tanaka N
J Int Med Res; 2002; 30(2):99-108. PubMed ID: 12025532
[TBL] [Abstract][Full Text] [Related]
16. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy.
Ono S; Aosasa S; Mochizuki H
Am J Surg; 1999 Jan; 177(1):78-82. PubMed ID: 10037314
[TBL] [Abstract][Full Text] [Related]
17. Glial cell line-derived neurotrophic factor enhances nuclear factor-kappaB activity and invasive potential in human pancreatic cancer cells.
Takahashi H; Funahashi H; Sawai H; Sakamoto M; Matsuo Y; Yamamoto M; Okada Y; Hayakawa T; Manabe T
Pancreas; 2004 Jul; 29(1):22-7. PubMed ID: 15211107
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model.
Furukawa K; Iida T; Shiba H; Fujiwara Y; Uwagawa T; Shimada Y; Misawa T; Ohashi T; Yanaga K
Oncol Rep; 2010 Oct; 24(4):843-50. PubMed ID: 20811662
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha induces apoptosis mediated by AEBSF-sensitive serine protease(s) that may involve upstream caspase-3/CPP32 protease activation in a human gastric cancer cell line.
Park IC; Park MJ; Choe TB; Jang JJ; Hong SI; Lee SH
Int J Oncol; 2000 Jun; 16(6):1243-8. PubMed ID: 10812002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
